Biodel (BIOD) Says Albireo Announces Positive Top-Line Phase 3 Results for Elobixibat in Japan

October 3, 2016 5:14 PM EDT Send to a Friend
As previously announced, Biodel Inc. (Nasdaq: BIOD) has entered into an amended and restated share exchange agreement (the “Exchange Agreement”) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login